Gene expression study of phase I and II metabolizing enzymes in RPTEC/TERT1 cell line: application in in vitro nephrotoxicity prediction

References

• Altuntas TG, Zager RA, Kharasch ED. (2003). Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2, 2-difluoro-1-(trifluoromethyl) vinyl ether (Compound A) in a human proximal tubular cell line. Toxicol Appl Pharmacol 193:55–65
   PubMed Web of Science ®Google Scholar
• Bach PH, Lock EA. 1987. Nephrotoxicity in the experimental and clinical situation. Part 1-2 Dordrecht: Springer Netherlands
   Google Scholar
• Beger RD, Sun J, Schnackenberg LK. (2010). Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243:154–66
   PubMed Web of Science ®Google Scholar
• Bloch KM, Yaqoob N, Sharma S, et al. (2015). Transcriptomic alterations induced by Monuron in rat and human renal proximal tubule cells in vitro and comparison to rat renal-cortex in vivo. Toxicol Res 4:423–31
   Web of Science ®Google Scholar
• Bowalgaha K, Miners JO. (2001). The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes. Br J Clin Pharmacol 52:605–9
   PubMed Web of Science ®Google Scholar
• Caldwell MD, Awad T, Johnson JA, et al. (2008). CYP4F2 genetic variant alters required warfarin dose. Blood 111:4106–12
   PubMed Web of Science ®Google Scholar
• Capdevila J, Wang W. (2013). Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension. Curr Opin Nephrol Hypertension 22:163
   PubMed Web of Science ®Google Scholar
• Chang I, Fukuhara S, Wong DK, et al. (2014). Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumor Biol 35:10223–30
   PubMed Web of Science ®Google Scholar
• Eaton DL, Bammler TK. (1999). Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 49:156–64
   PubMed Web of Science ®Google Scholar
• Erratico CA, Szeitz AS, Bandiera S. (2012). Oxidative metabolism of BDE-99 by human liver microsomes: predominant role of CYP2B6. Toxicol Sci 129:280–92
   PubMed Web of Science ®Google Scholar
• Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. (2001). The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism* 1 2. Drug Metabol Rev 33:273–97
   PubMed Web of Science ®Google Scholar
• Food US, Drug A. 2012. Drug Interaction Studies — Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations. Bethesda, MD: Center for Drug Evaluation and Research, FDA
   Google Scholar
• Frost & Sullivan. 2007. Drug discovery and development. In: Rang HP, ed. Edinburgh: Churchill Livingstone, Elsevier
   Google Scholar
• Fuchs TC, Hewitt P. (2011). Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J 13:615–31
   PubMed Web of Science ®Google Scholar
• Gamage N, Barnett A, Hempel N, et al. (2006). Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90:5–22
   PubMed Web of Science ®Google Scholar
• Helsby NA, Tingle MD. (2012). Which CYP2B6 variants have functional consequences for cyclophosphamide bioactivation?. Drug Metabol Dispos 40:635–7
   PubMed Web of Science ®Google Scholar
• Hiraoka H, Yamamoto K, Miyoshi S, et al. (2005). Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain. Br J Clin Pharmacol 60:176–82
   PubMed Web of Science ®Google Scholar
• Hrycay EG, Bandiera SM, eds. (2015). Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450. In: Advances in experimental medicine and biology. London: Springer, 851
   Google Scholar
• Jenkinson SE, Chung GW, Van Loon E, et al. (2012). The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflugers Archiv-Eur J Physiol 464:601–11
   PubMed Web of Science ®Google Scholar
• Kalsotra A, Turman CM, Kikuta Y, Strobel HW. (2004). Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol Appl Pharmacol 199:295–304
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Hankins DC, Thummel KE. (1995). Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 82:689–99
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Schroeder JL, Sheffels P, Liggitt HD. (2005). Influence of sevoflurane on the metabolism and renal effects of compound A in rats. Anesthesiology 103:1183–8
   PubMed Web of Science ®Google Scholar
• Kile ML, Houseman EA, Quamruzzaman Q, et al. (2013). Influence of GSTT1 genetic polymorphisms on arsenic metabolism. J Indian Soc Agric Statist 67:197–207
   PubMedGoogle Scholar
• Knights KM, Rowland A, Miners JO. (2013). Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). Br J Clin Pharmacol 76:587–602
   PubMed Web of Science ®Google Scholar
• Knights KM, Tsoutsikos P, Miners JO. (2005). Novel mechanisms of nonsteroidal anti-inflammatory drug-induced renal toxicity. Expert Opin Drug Metabol Toxicol 1:399–408
   PubMedGoogle Scholar
• Korashy HM, Elbekai RH, El-Kadi AOS. (2004). Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review. Xenobiotica 34:1–29
   PubMed Web of Science ®Google Scholar
• Kramer NI, Di Consiglio E, Blaauboer BJ, Testai E. (2015). Biokinetics in repeated-dosing in vitro drug toxicity studies. Toxicol In Vitro 30:217–24
   PubMed Web of Science ®Google Scholar
• Lash LH, Putt DA, Cai H. (2008). Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells. Toxicology 244:56–65
   PubMed Web of Science ®Google Scholar
• Lasker JM, Chen WB, Wolf I, et al. (2000). Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney ROLE OF CYP4F2 AND CYP4A11. J Biol Chem 275:4118–26
   PubMed Web of Science ®Google Scholar
• Li J, Li D, Tie C, et al. (2015). Cisplatin-mediated cytotoxicity through inducing CYP4A 11 expression in human renal tubular epithelial cells. J Toxicol Sci 40:895–900
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–8
   PubMed Web of Science ®Google Scholar
• Lohr JW, Willsky GR, Acara MA. (1998). Renal drug metabolism. Pharmacol Rev 50:107–42
   PubMed Web of Science ®Google Scholar
• Maier KG, Roman RJ. (2001). Cytochrome P450 metabolites of arachidonic acid in the control of renal function. Curr Opin Nephrol Hypertension 10:81–7
   PubMed Web of Science ®Google Scholar
• Mazoit JX, Sandouk P, Scherrmann JM, Roche A. (1990). Extrahepatic metabolism of morphine occurs in humans. Clin Pharmacol Ther 48:613–8
   PubMed Web of Science ®Google Scholar
• Mcdougle DR, Kambalyal A, Meling DD, Das A. (2014). Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase. J Pharmacol Exp Ther 351:616–27
   PubMed Web of Science ®Google Scholar
• Mutlib AE, Gerson RJ, Meunier PC, et al. (2000). The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats. Toxicol Appl Pharmacol 169:102–13
   PubMed Web of Science ®Google Scholar
• Nakamura A, Nakajima M, Yamanaka H, et al. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461–4
   PubMed Web of Science ®Google Scholar
• Omiecinski CJ, Remmel RP, Hosagrahara VP. (1999). Concise review of the cytochrome P450s and their roles in toxicology. Toxicol Sci 48:151–6
   PubMed Web of Science ®Google Scholar
• Raoof AA, Van Obbergh LJ, De Goyet JV, Verbeeck RK. (1996). Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney. Eur J Clin Pharmacol 50:91–6
   PubMed Web of Science ®Google Scholar
• Sarkis A, Roman RJ. (2004). Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Curr Drug Metabol 5:245–56
   PubMed Web of Science ®Google Scholar
• Seidegård RJ, Ekström MG. (1997). The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 105:791
   PubMed Web of Science ®Google Scholar
• Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, et al. (2009). Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol 6:281–9
   PubMed Web of Science ®Google Scholar
• Simms D, Cizdziel PE, Chomczynski P. (1993). TRIzol: a new reagent for optimal single-step isolation of RNA. Focus 15:532–5
   Google Scholar
• Simon-Friedt BR, Wilson MJ, Blake DA, et al. (2015). The RPTEC/TERT1 cell line as an improved tool for in vitro nephrotoxicity assessments. Biol Trace Element Res 166:66–71
   PubMed Web of Science ®Google Scholar
• Simon BR, Wilson MJ, Wickliffe JK. (2014). The RPTEC/TERT1 cell line models key renal cell responses to the environmental toxicants, benzo[a]pyrene and cadmium. Toxicol Rep 1:231–42
   PubMedGoogle Scholar
• Singh S, Li SSL. (2012). Bisphenol A and phthalates exhibit similar toxicogenomics and health effects. Gene 494:85–91
   PubMed Web of Science ®Google Scholar
• Smith HS. 2009. Opioid metabolismed. Mayo Clinic Proceed 84:613–24
   Google Scholar
• Tahara H, Kusuhara H, Endou H, et al. (2005). A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters. J Pharmacol Exp Ther 315:337–45
   PubMed Web of Science ®Google Scholar
• Thoustrup Saber A, Sørig Hougaard K. 2009. 141. Isoflurane, sevoflurane and desflurane. Arbete och Hälsa 43(9), 117 pp. ISBN: 978-91-85971-16-9
   Google Scholar
• Tiong HY, Huang P, Xiong S, et al. (2014). Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models. Mol Pharm 11:1933–48
   PubMed Web of Science ®Google Scholar
• Tseng E, Walsky RL, Luzietti RA, et al. (2014). Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide). Drug Metabol Dispos 42:1163–73
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP. (2000). Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616
   PubMed Web of Science ®Google Scholar
• Van Der Hauwaert C, Savary GG, Buob D, et al. (2014). Expression profiles of genes involved in xenobiotic metabolism and disposition in human renal tissues and renal cell models. Toxicol Appl Pharmacol 279:409–18
   PubMed Web of Science ®Google Scholar
• Woodland C, Ito S, Granvil CP, et al. (2000). Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sci 68:109–17
   PubMed Web of Science ®Google Scholar
• Zhou SF. (2009). Polymorphism of human cytochrome P450 2D6 and its clinical significance. Clin Pharmacokinetics 48:761–804
   PubMed Web of Science ®Google Scholar
• Zordoky BNM, Anwar-Mohamed A, Aboutabl ME, El-Kadi AOS. (2011). Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver. Drug Metabol Dispos 39:1440–50
   PubMed Web of Science ®Google Scholar